1-3 of 3
Jie Su
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer

Available to Purchase
Qianhui Yi, Weiguo Liu, Jung Hwa Seo, Jie Su, Moulay A. Alaoui-Jamali, Jun Luo, Rongtuan Lin, Jian Hui Wu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (5): 570–582.
https://doi.org/10.1158/1535-7163.MCT-22-0237
Published: 04 May 2023
View articletitled, Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer
Open the PDF for Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer

Available to Purchase
Sathyen A. Prabhu, Omar Moussa, Christophe Gonçalves, Judith H. LaPierre, Hsiang Chou, Fan Huang, Vincent R. Richard, Pault Y. M. Ferruzo, Elizabeth M. Guettler, Isabel Soria-Bretones, Laura Kirby, Natascha Gagnon, Jie Su, Jennifer Silvester, Sai Sakktee Krisna, April A. N. Rose, Karen E. Sheppard, David W. Cescon, Frédérick A. Mallette, Rene P. Zahedi, Christoph H. Borchers, Sonia V. del Rincon, Wilson H. Miller, Jr
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (2): 192–204.
https://doi.org/10.1158/1535-7163.MCT-22-0092
Published: 01 February 2023
View articletitled, Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
Open the PDF for Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition

Free
Tatiana Shorstova, Jie Su, Tiejun Zhao, Michael Dahabieh, Matthew Leibovitch, Mariana De Sa Tavares Russo, Daina Avizonis, Shivshankari Rajkumar, Ian R. Watson, Sonia V. del Rincón, Wilson H. Miller, Jr, William D. Foulkes, Michael Witcher
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2021) 20 (1): 64–75.
https://doi.org/10.1158/1535-7163.MCT-20-0259
Published: 05 January 2021
View articletitled, Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition
Open the PDF for Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition in another window
Includes: Supplementary data